Search results
Results from the WOW.Com Content Network
(Reuters) - Drugmaker Emergent BioSolutions said on Monday that it would reduce its workforce in Lansing, Michigan, by up to 70 roles as part of its ongoing restructuring efforts.
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. [2] It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
An analyst initiated coverage of Emergent BioSolutions (NYSE: EBS) stock as the last trading week of 2024 kicked off, and investors reacted quite positively to the move. Emergent, which benefits ...
Tuesday, Emergent BioSolutions Inc. (NYSE: ... This new procurement funding is from Emergent’s existing 10-year contract with the Biomedical Advanced Research and Development Authority.
On June 1, 2006, the DHHS awarded a $363 million contract to Emergent BioSolutions, (then Cangene Corporation) for 200,000 doses of BAT over five years for delivery into the US Strategic National Stockpile (SNS). [10] The CDC began supplying doses to the SNS in 2007 under a now $427 million contract with the DHHS, according to a Cangene press ...
Advanced Bio-Treatment (ABT) is a biohazard response and remediation company operating in twenty-eight states. The company employs a multitude of cleanup teams specializing in crime scene cleanup . Day-to-day business operations are overseen by a customer service driven team from the company’s corporate office located in Jacksonville, Florida .
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.
The Alliance for Biosecurity is a group of pharmaceutical and biotechnology companies that work to create preventive measures and treatments for severe infectious diseases. [ 3 ] Within the U.S. federal government, the Biomedical Advanced Research and Development Authority (BARDA) and the Project BioShield Special Reserve Fund (SRF) provide ...